cyclosporine has been researched along with 1-o-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, BR; Bochkov, VN; Graier, WF; Hofer, E; Huber, J; Leitinger, N; Lucerna, M; Malli, R; Mechtcheriakova, D | 1 |
1 other study(ies) available for cyclosporine and 1-o-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine
| Article | Year |
|---|---|
Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca(++)/NFAT.
Topics: Calcineurin Inhibitors; Calcium; Cells, Cultured; Cyclosporine; DNA; DNA-Binding Proteins; Early Growth Response Protein 1; Endothelium, Vascular; Enzyme Activation; Humans; I-kappa B Proteins; Immediate-Early Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; NFATC Transcription Factors; Nuclear Proteins; Oxidation-Reduction; Phospholipases A; Phospholipid Ethers; Phosphorylation; Thromboplastin; Transcription Factors; Umbilical Veins | 2002 |